Galderma buys into Honeywell manufacturing management systems

Galderma, the Swiss dermatological research healthcare joint venture between L’Oreal and Nestle, has selected a trio of manufacturing systems for process management from pharmaceutical sector supplier Honeywell POMS. The firm has selected POMS MES (manufacturing executions system), CMS (clinical manufacturing solution) and POMS eSpec electronic specification system, the latter for R&D and product development. First phase of the implementation is already underway with POMS MES 4.3 going into Montreal, Canada. Subsequent installations will be at multiple sites in France and then the R&D facilities in Annecy and Sophia Antipolis, also in France. Says Galderma manufacturing and technologies vice president Phillippe Lancery: “The POMS offerings equip our company to meet the demands of FDA regulation 21 CFR part 11 and potentially shorten our time to market.” POMS MES, CMS and eSpec are all part of Honeywell’s Unified Manufacturing systems for the pharmaceutical, healthcare and consumer packaged goods industries.